BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33918752)

  • 1. Generating New FANCA-Deficient HNSCC Cell Lines by Genomic Editing Recapitulates the Cellular Phenotypes of Fanconi Anemia.
    Errazquin R; Sieiro E; Moreno P; Ramirez MJ; Lorz C; Peral J; Ortiz J; Casado JA; Roman-Rodriguez FJ; Hanenberg H; Río P; Surralles J; Segrelles C; Garcia-Escudero R
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutated
    Bertola N; Degan P; Cappelli E; Ravera S
    Cells; 2022 Jul; 11(15):. PubMed ID: 35954197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
    Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
    Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic
    Lach FP; Singh S; Rickman KA; Ruiz PD; Noonan RJ; Hymes KB; DeLacure MD; Kennedy JA; Chandrasekharappa SC; Smogorzewska A
    Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33172906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
    Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
    Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
    Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer.
    Stoepker C; Ameziane N; van der Lelij P; Kooi IE; Oostra AB; Rooimans MA; van Mil SE; Brink A; Dietrich R; Balk JA; Ylstra B; Joenje H; Feller SM; Brakenhoff RH
    Cancer Res; 2015 Sep; 75(17):3543-53. PubMed ID: 26122845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fanconi anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments.
    Kachnic LA; Li L; Fournier L; Willers H
    Cancer Lett; 2010 Jun; 292(1):73-9. PubMed ID: 20034732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48.
    Velimezi G; Robinson-Garcia L; Muñoz-Martínez F; Wiegant WW; Ferreira da Silva J; Owusu M; Moder M; Wiedner M; Rosenthal SB; Fisch KM; Moffat J; Menche J; van Attikum H; Jackson SP; Loizou JI
    Nat Commun; 2018 Jun; 9(1):2280. PubMed ID: 29891926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FANCA gene mutation analysis in Fanconi anemia patients].
    Chen F; Peng GJ; Zhang K; Hu Q; Zhang LQ; Liu AG
    Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):616-8. PubMed ID: 16532972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
    van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
    DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer.
    Montanuy H; Martínez-Barriocanal Á; Antonio Casado J; Rovirosa L; Ramírez MJ; Nieto R; Carrascoso-Rubio C; Riera P; González A; Lerma E; Lasa A; Carreras-Puigvert J; Helleday T; Bueren JA; Arango D; Minguillón J; Surrallés J
    Clin Cancer Res; 2020 Jun; 26(12):3044-3057. PubMed ID: 32005748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
    van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
    Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers.
    Lombardi AJ; Hoskins EE; Foglesong GD; Wikenheiser-Brokamp KA; Wiesmüller L; Hanenberg H; Andreassen PR; Jacobs AJ; Olson SB; Keeble WW; Hays LE; Wells SI
    Clin Cancer Res; 2015 Apr; 21(8):1962-72. PubMed ID: 25609062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promyelocytic Leukemia Proteins Regulate Fanconi Anemia Gene Expression.
    Munkhjargal A; Kim MJ; Kim DY; Jeon YJ; Kee YH; Kim LK; Kim YH
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complex.
    Jeong E; Lee SG; Kim HS; Yang J; Shin J; Kim Y; Kim J; Schärer OD; Kim Y; Yeo JE; Kim HM; Cho Y
    Nucleic Acids Res; 2020 Apr; 48(6):3328-3342. PubMed ID: 32002546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated ATM gene expression and activated DNA crosslink-induced damage response checkpoint in Fanconi anemia: implications for carcinogenesis.
    Yamamoto K; Nihrane A; Aglipay J; Sironi J; Arkin S; Lipton JM; Ouchi T; Liu JM
    Mol Med; 2008; 14(3-4):167-74. PubMed ID: 18224251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
    Román-Rodríguez FJ; Ugalde L; Álvarez L; Díez B; Ramírez MJ; Risueño C; Cortón M; Bogliolo M; Bernal S; March F; Ayuso C; Hanenberg H; Sevilla J; Rodríguez-Perales S; Torres-Ruiz R; Surrallés J; Bueren JA; Río P
    Cell Stem Cell; 2019 Nov; 25(5):607-621.e7. PubMed ID: 31543367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer.
    Webster ALH; Sanders MA; Patel K; Dietrich R; Noonan RJ; Lach FP; White RR; Goldfarb A; Hadi K; Edwards MM; Donovan FX; Hoogenboezem RM; Jung M; Sridhar S; Wiley TF; Fedrigo O; Tian H; Rosiene J; Heineman T; Kennedy JA; Bean L; Rosti RO; Tryon R; Gonzalez AM; Rosenberg A; Luo JD; Carroll TS; Shroff S; Beaumont M; Velleuer E; Rastatter JC; Wells SI; Surrallés J; Bagby G; MacMillan ML; Wagner JE; Cancio M; Boulad F; Scognamiglio T; Vaughan R; Beaumont KG; Koren A; Imielinski M; Chandrasekharappa SC; Auerbach AD; Singh B; Kutler DI; Campbell PJ; Smogorzewska A
    Nature; 2022 Dec; 612(7940):495-502. PubMed ID: 36450981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.